Form 4: FITTERS Diversified Sells BGMS Shares

FITTERS Diversified Berhad, a 10% owner and director of Bio Green Med Solution, Inc., reported the sale of 142,000 common shares at $5.293 per share.

Summary

• FITTERS Diversified Berhad, a 10% owner and director of Bio Green Med Solution, Inc. (BGMS), reported an insider transaction.
• The transaction involved the sale of 142,000 shares of BGMS common stock.
• The shares were sold at a price of $5.293 per share, totaling approximately $751,606.
• Following this transaction, FITTERS Diversified Berhad beneficially owns 557,158 shares of BGMS common stock.
• The transaction date was October 8, 2025.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-scheduled.

Sentiment

Score: 4

Explanation: The sale of a significant number of shares by a 10% owner and director is generally viewed as a negative signal, although the transaction being under a Rule 10b5-1 plan suggests it was pre-planned and not necessarily based on new adverse information.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, suggesting it was pre-scheduled and not necessarily based on new material non-public information.

Negatives

• A significant insider sale by a 10% owner and director could be perceived negatively by the market.
• The sale of 142,000 shares represents a substantial divestment by a key stakeholder.

Risks

• Potential negative market reaction to insider selling, which could put downward pressure on the stock price.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The sale of 142,000 common shares by FITTERS Diversified Berhad, a 10% owner and director of Bio Green Med Solution, Inc., constitutes a related party transaction.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a lack of confidence, potentially leading to negative sentiment or selling pressure on the stock.
• Management/Board: The transaction by a director and significant owner could raise questions about internal perspectives on the company's future.

Key Dates

Recommendation

While the sale of shares by a 10% owner and director can be a negative signal, the transaction was executed under a Rule 10b5-1 plan, suggesting it was pre-scheduled and not necessarily indicative of new negative developments. Investors should hold and monitor future insider activity and company performance rather than reacting solely to this single transaction.

Keywords

Bio Green Med Solution, BGMS, FITTERS Diversified Berhad, Insider Sale, Form 4, SEC Filing, Stock Transaction, Director Sale, 10% Owner, Equity Sale, Rule 10b5-1